A retrospective evaluation of radionuclide liver and spleen scintigraphy (LS), ultrasonography <US), and computed tomography (CT) was performed in 88 patients who had pathologically proven cutaneous melanoma. In patients who had all three examinations (n=24), the matrix analysis showed that CT was significantly more sensitive (0.94) in detecting intra-abdominal metastasis when compared to US (0.62, P<0.05) and LS (0.38, P<O.OI). Sixty-four patients had only US and LS studies. In this group of patients US was found to be more sensitive than LS, 0.88 and 0.54 respectively (P< 0.01).Furthermore, when CT was compared with US, CT was shown to detect metastases significantly earlier than US (P=0.03). Overall, CT provided the most accurate means for detecting the intra-abdominal metastases of cutaneous melanoma.
Introduction
During the past decade rapid advances in ultrasonography <US) and computed tomography have allowed the clinician to obtain more information of the extent of disease and to assess the results of therapy in the evaluation of abdominal-pelvic neoplasms. These modalities as well as radionuclide liver and spleen scintigraphy (LS) are the most commonly employed non-invasive diagnostic procedures used in our hospital for the evaluation of intra-abdominal metastatic disease.
Until recently, LS had been used as the screening modality of choice in suspected hepatic disease, with US or CT used as an adjunct to determine whether a quantitive abnormality represented a true lesion or an anatomical defect1,2. However, because of the recent improvements in US and CT imaging and the limited information available in the diagnosis of extrahepatic and pelvic metastases by LS, US and CT4,ll, a reappraisal in our diagnostic approach is in order.
This report is a retrospective comparison of the information provided by LS. US and CT in patients with intra-abdominal metastatic melanoma. The sensitivity and specificity of the examinations both for the detection of space-occupyinglesions and for the assessment of extent of metastatic disease are emphasized.
Materials and methods

Subjects
The computerized data base for Northern Alberta at the Cross Cancer Institute contained information of 496 patients with malignant melanoma reported from 1981 to 1986. Of these patients, 88 had US examinations of the abdomen and/or pelvis within our department. These patients were also examined by LS and CT in various combinations. All patients had pathologically proven cutaneous malignant melanoma in various clinical stages. The patients ranged in age from 17 to 72 years; 46 were men and 42 were women. Of the 88 patients, 85 had no other known neoplastic disease, 3 had both basal cell carcinoma and melanoma.
Methods LS were obtained after the intravenous administration of approximately 5 mCi(l75MBq) ofTc 99 m sulphur colloid with a wide field view of gamma camera.
Real-time US were performed with either a Technicare MCC or Autosector Scanner. A 3.5 MHz realtime annular transducer with variable focus was used. Both transverse and longitudinal scans were obtained as needed.
CT scans were obtained with a General Electric CT 9800 Scanner. These scans were performed through the upper abdomen and continued into the pelvis in some cases to confirm US or suggestive radiological findings. Most patients are given 100 ml Iopamidol aSOVUE 300) intravenously before scanning for better evaluation of abdominal structures. Scans were obtained at 10 mm intervals.
Final diagnosis
The 'final diagnosis' of the presence or absence of intra-abdominal metastases was made on the basis of those with unequivocal evidence of metastases in two or more modalities or where only one modality showed the metastases well but other radiological. biochemical, pathological, or clinical documentation was obtained.
Criteria for evaluation
The different criteria used were as follows: (Abbreviations: TP=true-positive results; FP=false-positive; TN =true-negative. FN = false-negative).
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Data analysis
Comparisons were made in the following manner: (1) Patients who were examined by all 3 modalities, LS, • Each site was examined in every patient except for LS which only examined these sites. 24 cases were examined by all three tests, 16 cases had metastases 19 CT studies were abnormal, 9 had more than one site of metastases 12 US studies were abnormal. 3 had more than one site of metastases 8 LS studies were abnormal, 1 had more than one site of metastases 580 Journal of the Royal Society of Medicine Volume 81 October 1988 US, and CT were placed in one group; (2)Patients who were examined with LS and US were placed in the other group.
To determine which modality (US or CT) was the earliest method of detecting abdominal metastases, patients with positive 'final diagnosis' and who were examined by US and CT were placed in one group. The earliest positive test date (US or CT) was compared with the other test date (US or CT) if they occurred within a one month interval. If the CT and US examinations were performed more than a month apart, the patient was discarded from the analysis. Data were analysed by tests of proportion and the binomial distribution. P values less than 0.05 were considered statistically significant.
Results
Metastases were identified in 40 of the 88 patients (45%). This included 0/6 patients (0%) with Clark level II melanoma, 14/29 patients (48%) with level ill, 16/30 patients (53%) with level IV, 10/13 patients (77%) with level V, and 0/10 patients (0%) with no Clark classifications. Tables 1 to 3 . Nine CT, 3 US, and 1 LS examination had more than one metastatic site. Sixteen LS examinations showed no abnormalities. Ten of these 16 were false negative. Out of these 10 cases, 5 were extrahepatic, 3 hepatic, and 2 hepatic with extrahepatic metastases. Eight LS were abnormal. Two of these 8 cases were false positive. These were also found to be abnormal by US and CT. One of these cases was found to be normal at autopsy and the other was found to have had a liver cyst at biopsy.
Twelve US examinations showed no abnormalities. Six of these were false negative examinations. All of these 6 cases were positive on CT and 2 of these by LS. Of these patients, the sites involved were: liver 3, lymph nodes 4, abdomen 2, pelvis 1, pancreas 1. Twelve patients had US studies thatwere judged to be abnormal. Two of the cases were false positive. These two were also shown to be abnormal by LS and CT and they were described as above.
Five CT examinations showed no abnormalities. One of these was false negative. The patient was found to have extensive liver metastases by US and LS. Nineteen CT examinations were shown to be abnormal. Four of these 19 were false positive, being proven by other radiological, pathological, biochemical and clinical criteria.
The standard matrix analysis revealed that CT was the most sensitive modality (0.94) followed by US (0.62) and LS (0.38). When compared to other modalities, CT was significantly more sensitive than US (P< 0.05) and LS (P< 0.01), but the results of the differences in specificity among these three examinations were not statistically significant. ' Group 2 (LS and US): Sixty-four patients were examined by both US and LS. Of the 64 cases, 24 had metastases. The results of the findings are found in Tables 4 to 6. Seven US had more than one metastatic site.
Forty-two patients had normal US studies. Three of these 42 were false negative. These were shown by LS to have liver metastases. Twenty-two US examinations were found to be abnormal. One false positive was found in this group.
Table 4. Detection of intra-abdominal metastases from melanoma in patients who had LS and US examinations
• 12 false positive and 11 false negative • 1 false positive and 3 false negative melanoma. The extent of surgery for melanoma is based upon the best assessment of the extent of disease. The identification of distant tumour spread requires the use of adjuvant systemic chemotherapy in addition to surgical removal of known bulky metastases". The ability of any modality to demonstrate the presence and extent of disease is of primary concern to the physician involved. This information becomes important in the staging and diagnosis as well as in therapy. Other factors such as cost and availability are obviously involved.
The value ofLS in assessing liver disease has been well documentedv'P, In two reviews, LS was found to have the greatest sensitivity as compared to US and CT. However, LS specificity was the lowest as compared with US and CT. In the current study, LS was found to be significantly less sensitive in the detection of intra-abdominal metastases when compared with CT in group 1, 0.38 and 0.94 respectively (P< 0.01). In group 2, the sensitivity of LS (0.54) was again significantly less sensitive than US (0.88) with P< 0.01. This can partly be explained by the inability of LS to demonstrate the extent of disease as well as the cross-sectional imaging modalities.
US has improved with the advent of real-time scanning and is recommended as an initial liver screening technique!'. In fact, the value of US in malignant melanoma as an initial screening method has been emphasized by Bernardino and Goldstein'P, In the present study US was found to be less sensitive than CT in detecting abdominal metastases in group 1, 0.62 and 0.94 respectively (P< 0.05). But US was significantly more sensitive than LS in group 2, 0.88 and 0.54 respectively (P<O.OI). One of the greatest advantage of US is that, besides detecting hepatic disease, abnormalities in extrahepatic locations are found, thereby determining the true extent of disease process. This is especially important in the cancer patient as other findings may affect the staging of disease and subsequent therapy.
If 'state of the art' equipment is compared, CT is probably the all-around best modality for intraabdominal metastaseat-, The result of our study agrees with this observation. In group 1, in which patients had all three modalities performed, CT was shown to be more sensitive in detecting intraabdominal metastases when compared to US and LS, 0.94, 0.62, and 0.38 respectively. Most importantly, the results were significant when compared; to US (P< 0.05) and LS (P< 0.01). CT was also shown to detect more metastatic sites than US or LS, 9, 3 and 1, respectively. Furthermore, CT was found to detect abdominal metastases significantly earlier than US (P=0.03).
Conclusion
The results of CT, US and LS examination have been reviewed following a retrospective study of 88 patients out of a total series of 496 patients reported to the computerized data base for Northern Alberta.
CT has been shown to demonstrate metastases significantly earlier than the US or LS, and to detect significantly more metastatic sites.
US was shown to be more sensitive than LS, however, when cost/availability is of concern, US has a place as an alternative to CT.
** NS
LS/US Results
Sensitivity Specificity
• Each site was examined by US in every patient but LS only examined these sites 64 cases were examined by US and LS, 24 cases had metastases 22 US studies were abnormal, 7 had more than one site of metastases 25 LS studies were abnormal, none had more than one site of metastases Thirty-nine LS studies were normal. Eleven cases of this group were false negative. All 11 patients were found to have abdominal metastases by US studies: 3 hepatic, 5 hepatic and extrahepatic, and 3 extrahepatic metastases. Twenty-five patients who had the LS examination were shown to be abnormal, and 12 patients were false positive. Two of these 12 cases can be attributed to prominent hepatic vasculatures. All 12 cases were proved to be free of metastases by US, biochemistry, and clinical findings.
The standard matrix analysis revealed that US was significantly more sensitive (0.88) than LS (0.54) (P<O.OI); specificities were (0.98) and (0.70), respectively. The difference in specificity, however, was not statistically significant.
Discussion
Malignant melanoma is the most malignant form of skin cancer. Reliable cancer statistics from around the world reveal an increase in the incidence of and rate of death from melanoma", Melanoma is estimated to comprise approximately 3% of the malignancies that are diagnosed each year in the USA 7 • To date surgery remains the only curative treatment of Earliest diagnostic method Twenty-five patients in this study group had both CT and US performed on them during the course of their disease. Nineteen patients in this group were positive for metastases. 7/19 had CT and US examinations done more than a month apart and these were excluded from the analysis. Of the remaining 12 cases, CT demonstrated the lesion first in 5 cases and CT and US were simultaneous 7 times. Ignoring the 7 tie cases, the remaining cases showed that CT can detect metastases significantly earlier than US (P=0.03).
